📰 Merck Sharp News
Page 108 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 27, 2021
Taipei, Nov. 27 (CNA) Taiwan's plan to procure the oral antiviral drug, molnupiravir, remains unchanged, Health and Welfare Minister Chen Shih-chung (陳時中) said Saturday, although the drug has been shown to be less effective in reducing COVID-19 hospitalizations and deaths in its final analysis.